380-41-6

Usage

Uses

Used in Pharmaceutical Synthesis:
ETHYL 2,2-DIFLUORO-3-HYDROXYPROPIONATE is used as a key intermediate in the production of various pharmaceuticals. Its unique structure allows for the creation of new drug molecules with improved properties, such as enhanced bioavailability, selectivity, and potency.
Used in Agrochemical Production:
In the agrochemical industry, ETHYL 2,2-DIFLUORO-3-HYDROXYPROPIONATE serves as a building block for the synthesis of pesticides and other crop protection agents. Its incorporation into these compounds can lead to more effective and environmentally friendly products.
Used in Medicinal Chemistry and Drug Discovery:
ETHYL 2,2-DIFLUORO-3-HYDROXYPROPIONATE is utilized as a versatile starting material in medicinal chemistry for the development of novel therapeutic agents. Its distinct functional groups and structural attributes make it a promising candidate for the design and synthesis of new drugs with potential applications in various therapeutic areas.
Used in Organic Compound Production:
ETHYL 2,2-DIFLUORO-3-HYDROXYPROPIONATE also finds application as a precursor in the synthesis of a wide range of organic compounds. Its reactivity and compatibility with various chemical reactions enable the production of diverse chemical entities for use in different industries, including specialty chemicals, materials science, and more.

Upstream product

• 2368-37-8 2,2-difluoro-3-hydroxy-propionic acid 
• 116-14-3 polytetrafluoroethylene 
• 50-00-0 formaldehyd 
• 64-17-5 ethanol 
• 79-38-9 Chlorotrifluoroethylene 
• 667-27-6 Ethyl bromodifluoroacetate 
• 7440-66-6 zinc 
• 765-63-9 2,2,3,3-tetrafluorooxetane 
• 127-09-3 sodium acetate 

Relevant academic research and scientific papers

Fluoroethercarboxylic acid and production method thereof, surfactant, method of producing fluoropolymer and aqueous dispersion used thereof

The invention provides a fluoroethercarboxylic acid which is represented by the general formula (I): [in-line-formulae]Rf1OCHFCF2ORf2COOM??(I)[/in-line-formulae] wherein Rf1 represents a partially or fully fluorinated alkyl group, which may optionally be interrupted with one or more oxygen atoms, Rf2 represents a partially or fully fluorinated alkylene group, which may optionally be interrupted with one or more oxygen atoms, and M represents a monovalent alkali metal, NH4 or H. The fluoroethercarboxylic acid can be suitably used as a surfactant and is low in bioaccumulation. The invention is also a method of fluoropolymer production and an aqueous fluoropolymer dispersion, using the fluoroethercarboxylic acid as a surfactant.

S-adenosyl methionine decarboxylase inhibitors

The adenosine derivatives represented by the following formula: STR1 and the pharmaceutically acceptable salts thereof wherein R is H or C1 -C7 alkyl, Q is the moiety of the formula STR2 wherein V is H or --COOH X is H, F, Cl, Br, and Z is H, F, Cl, or Br. These compounds are inhibitors of S-adenosylmethione decarboxylase and are useful for treating parasitic infections.

5'-amine substituted adenosine analogs as immunosuppressants

The present invention relates to a method of effecting immunosuppression in a patient in need thereof comprising administering to said patient an effective immunosuppressive amount of certain 5'-amine substituted adenosine analogs.

S-Adenosylmethionine decarboxylase inhibitors

This invention relates to novel chemical compounds useful as S-adenosylmethionine decarboxylase inhibitors, of the formula, , H2N-Q- wherein R1 is H or F, n is 1 or 2, V1 is H or CH3, V2 is H or COOH, and each of W, X, Y, and Z are H, F, Cl or Br. To the processes useful for their preperation and to their use in the treatment of a variety of condition and disease states associated with a rapid proliferation of cell growth.

Novel fluorophosphonate nucleotide derivatives

This invention relates to fluoromethylphosphonate derivatives of certain nucleosides, to methods for their preparation and to their use as antiviral and antitumoral agents.